AJANTA PHARMA
Back to Balance Sheet
|
AJANTA PHARMA Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹-71 Cr | ₹-76 Cr | ₹-26 Cr | ₹0.95 Cr | ₹46 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of AJANTA PHARMA ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2026 | ₹-71 Cr |
| Mar2025 | ₹-76 Cr |
| Mar2024 | ₹-26 Cr |
| Mar2023 | ₹0.95 Cr |
| Mar2022 | ₹46 Cr |
How is Deferred Tax Assets / Liabilities of AJANTA PHARMA Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹-71 Cr | Negative | |
| Mar2025 | ₹-76 Cr | Negative | |
| Mar2024 | ₹-26 Cr | Negative | |
| Mar2023 | ₹0.95 Cr | -97.95 | |
| Mar2022 | ₹46 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of AJANTA PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AJANTA PHARMA | ₹43,127.3 Cr | 4.5% | 12.9% | 30.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹468,458.0 Cr | 0.7% | 8.1% | 16% | Stock Analytics | |
| DIVIS LABORATORIES | ₹193,383.0 Cr | 7% | 10.2% | 3.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹169,829.0 Cr | 2.5% | 11.3% | 49.6% | Stock Analytics | |
| CIPLA | ₹116,164.0 Cr | -0.3% | 4.1% | -3.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,648.0 Cr | -3.2% | -3.9% | -3% | Stock Analytics | |
AJANTA PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AJANTA PHARMA | 4.5% |
12.9% |
30.6% |
| SENSEX | 0.9% |
2.2% |
-7.5% |
You may also like the below Video Courses